Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrarosa in Genitourinary Syndrome of Menopause
NCT03782480Phase 3Unknown
- Sponsor
- The Centers for Vulvovaginal Disorders
- Start
- Mar 2019
- Primary completion
- Jan 2021
- Countries
- 1
01
Overview
A Phase 3 trial of dehydroepiandrosterone in genitourinary syndrome of menopause (GSM), Vulvovaginal atrophy (VVA), dyspareunia, sponsored by The Centers for Vulvovaginal Disorders. Status: unknown.
02
Drugs
dehydroepiandrosterone
03
Conditions
genitourinary syndrome of menopause (GSM)Vulvovaginal atrophy (VVA)dyspareunia
Beyond the preview
Go deeper on NCT03782480.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03782480.